Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Takeda Singapore receives coveted HR accolades by creating an exceptional people experience
2022-05-09 09:00
ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome
2022-05-09 07:00
Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report
2022-05-07 09:00
Antengene to Participate in Three Upcoming Investor Conferences in May/June
2022-05-06 08:30
World Lupus Federation Global Survey of People Living with Lupus finds 87% Report at Least One Major Organ Affected by the Disease
2022-05-06 07:00
Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers
2022-05-06 05:00
Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers
2022-05-05 23:00
HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study
2022-05-05 22:12
TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED's lead drug platform candidate ILB®
2022-05-05 20:40
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
2022-05-05 20:27
Leading HealthTech AI company NuraLogix announces new partnership with LaFiya TeleHealth
2022-05-05 20:15
Clinical Trial Approval For ReCOV In The PRC And The Overseas Clinical Trial Progress Of ReCOV
2022-05-05 11:55
Panoramic Atlases of Life Published in Cell Mark Establishment of SpatioTemporal Omics Consortium
2022-05-05 09:00
Panoramic Atlases of Life Published in Cell Mark Establishment of SpatioTemporal Omics Consortium
2022-05-05 09:00
First Patient Dosed in Phase II Renal Cancer Theranostics Study
2022-05-05 05:00
Nanoform launches "STARMAP® Online" placing AI-power at the fingertips of medicine developers
2022-05-04 14:35
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*
2022-05-04 14:00
China Mobile Hong Kong Launches Online Medical App "Dr. HK"
2022-05-04 12:00
European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
2022-05-04 06:00
3M Littmann CORE Digital Stethoscope Honored in Fast Company's 2022 World Changing Ideas Awards
2022-05-04 04:50
1
163
164
165
166
167
502